Jean-Emmanuel Kurtz

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Coronary Artery Bypass

Epidermal Growth Factor Receptor

Neuropathic Pain

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of breast cancer

JMIR mHealth and uHealth

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jean-Emmanuel Kurtz, Eric Pujade-Lauraine, Ana Oaknin, Lisa Belin, Katharina Leitner, David Cibula, Hannelore G Denys, Ora Rosengarten, Manuel J Rodrigues, Nikolaus de Gregorio, Jerónimo Martínez-Garcia, Edgar Petru, Roman Kocian, Ignace Vergote, Patricia Pautier, Barbara Schmalfeldt, Lydia Gaba, Stephan Polterauer, Marie-Ange Mouret Reynier, Jalid Sehouli, Cristina Churruca, Frédéric Selle, Florence Joly Lobbedez, Veronique D'Hondt, Émilie Bultot-Boissier, Coriolan Lebreton, Jean-Pierre Lotz, Rémy Largillier, Pierre Etienne Heudel, Florian Heitz, null null
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nicolas Penel, Sylvie Bonvalot, Marie-Cécile Le Deley, Antoine Italiano, Camille Tlemsani, Diane Pannier, Clémence Leguillette, Jean-Emmanuel Kurtz, Maud Toulmonde, Julien Thery, Daniel Orbach, Pascale Dubray-Longeras, Benjamin Verret, François Bertucci, Cécile Guillemet, Lucie Laroche, Armelle Dufresne, Jean Yves Blay, Axel Le Cesne
Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value. International journal of cancer (2023)
Simon Nannini, Nicolas Penel, Emmanuelle Bompas, Thibault Willaume, Jean-Emmanuel Kurtz, Justine Gantzer
Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study. JMIR mHealth and uHealth 10 (11) (2022)
Laura Bender Somme, Jean-Emmanuel Kurtz, Thierry Petit, Xavier Pivot
Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size. Journal of breast cancer 23 (6) (2020)